In general, in order to overcome the poor stability and weak immunogenicity of tumor antigenic peptides, the STING-activating peptide nanovaccine based on HSA and biodegradable MnO2 was constructed for tumor prevention and treatment. The gene discussed is STING1; the disease is neoplasm.